chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient presented back to clinic one day after receiving a dose of pneumococcal vaccine, complaining of fatigue, body ache, and local swelling in the arm where the dose had been administered. Provider considered differential diagnosis of allergic reaction vs cellulitis and treated for both. Patient received an oral prednisone taper over 5 days, oral diphenhydramine 50mg TID x 1 week, and cephalexin 500mg TID x10 days. Upon followup by phone the next day, patient's symptoms had completely resolved. Patient last previous dose of pneumococcal vaccine had reportedly been given 2005 at another clinic. Syptoms: 1. fatigue, body ache, local swelling Treatment Drugs Used: 1- PREDNISONE Dose: 50 taper to 10mg Units: MG Freq: EVERY DAY Route: PO 2- DIPHENHYDRAMINE Dose: 50 Units: MG Freq: TID Route: PO 3-CEPHALEXIN Dose: 500 Units: MG Freq: TID Route: PO
In the 5 1/2 weeks following the first Covid-19 shot, and including the second one at the three-week mark, I had three small skin breaks that were followed by first-ever unusual immune system responses:  (1) a small wart-like lesion on a finger (circular white mound with a dark center spot), then I pulled a cuticle hangnail on that same finger and developed a huge, purulent bacterial infection that had to be lanced, drained, and treated with antibiotics; (2) a small paper cut on another finger developed a similar wart-like lesion; and (3) I scratched off a tiny part of a forearm scab near my elbow and developed an enlarging, deepening boil that had to be cut and expressed  repeatedly until it started to heal spontaneously with a few warm soaks.  I have never had a wart or boil before in 75 years.  I feared the risk of sepsis to my bilateral hip joint replacements.  It seemed like the mRNA vaccine was commanding all of my antibody formation and leaving nothing in my immune system to address routine small bacterial intrusions.  After the vaccine did its job, the other infections resolved except for the appearance of the two wart-like lesions.
A LITTLE LETHARGIC; ONE DIZZY SPELL; CHILLS; HEADACHE; VOMITING; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 09-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 09-APR-2021, the subject experienced vomiting. On 09-APR-2021, the subject experienced chills. On 09-APR-2021, the subject experienced headache. On 10-APR-2021, the subject experienced a little lethargic. On 10-APR-2021, the subject experienced one dizzy spell. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from vomiting, chills, and headache on APR-2021, and the outcome of a little lethargic and one dizzy spell was not reported. This report was non-serious.
stiff neck; a sore left arm pit; a swollen bump in the middle of her left arm pit; This is a spontaneous report from a contactable consumer. This consumer reported for a female patient (wife). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number and expiry date were not reported), dose 1 via an unspecified route of administration, administered in left arm on 20Feb2021 as DOSE 1, SINGLE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter stated that the patient got first Pfizer COVID-19 Vaccine shot last Saturday on 20Feb2021 and clarified that the patient was scheduled to get their second COVID-19 Vaccine on 18Mar2021. The reporter stated that the patient woke up in morning of 25Feb2021, 5 days after getting the COVID-19 Vaccine, with a stiff neck, a sore left arm pit, and a swollen bump in the middle of her left arm pit. He clarified his wife received her COVID-19 Vaccine in her left arm, and she still has the swollen bump in the middle of her left arm pit. The patient declined to complete a report over the phone because the patient had to go to work. The clinical outcome of the events stiff neck and a sore left arm pit was unknown. Outcome for the event a swollen bump in the middle of her left arm pit was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt receive flu and HPV vaccine. Became stiff immediately following HPV. Eyes deviated to (L),increase salivation, (R)arm raised to chest. Placed on floor.Nasal cannula @2L applied. PO 100%. Resp equal and unlabored. Able to focus on father after approx 1 min. Began talking and laughing/crying. Sat pt and given juice(had not eaten since 1100)Visidex 112. PO 99-100% on room air. While sitting in chair, stated difficulty breathing. PO 94-95% on room air. Placed on nasal cannula @2L. States improvement. PO 100%.Resp unlabored. C/o numbness to nose. Cap refill <3secs. Pt talking(tearful at times)and anxious. Dr. notified. Pt to to PED's ER via wheelchair and monitored and released later.
"Weird feeling in whole right arm" Then localized in right upper arm. Lump developed on 8/18/16 and continued pain, stinging. Mild erythema.
When I am in the heat for an hour or so:  Vertigo, disequilibrium, presyncope, and lightheadedness.
Heart arrhythmia- persistent, will skip every 3rd or 4th beat for hours at a time. Causes breathlessness.
doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2021 at 1:30 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 11-Jan-2021 at 1:30 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 79.28 for dose administered on 11-Jan-2021.  No concomitant medications were reported.  Batch number 041L20A underwent temperature excursion on 11-Jan-2021 with temperature 34 degrees Fahrenheit from 09:00 AM. These vials were moved to fridge on 08-Jan-2021 and beyond use date for the vials was reported as 7-Feb-2021. Product moved to clinic on 11-Jan-2021 Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.   This case was linked to MOD-2022-566976 (E2B Linked Report).; Sender's Comments:  MOD-2022-566976:Master Case (Same Reporter)
lt arm from just above elbow to shoulder is red, swollen & hot;cellulitis to PMD today;
Patient complained of soreness and a big area of rash on the lower left arm 2 days after getting the vaccine.
injection site pain, tiredness, headache, muscle pain, chills, joint pain, fever, injection site swelling, injection site redness, nausea, feeling unwell, lymphadenopathy, diarrhea, vomiting, arm pain, fatigue, lower abdominal pain.
4/15/2021 approximately 1030 am client found to be AMS, non-responsive, aphasic, aphagic, left-sided facial droop, teeth clenched, left eye closes, right eye with deviated gaze.  911 called, client to hospital ER, work up/evaluation, admission for stroke related to blood clots found left frontal and right temporal lobes, per spouse. Client discharged 4 days later to home s/p CVA, bed-bound, remains aphasic, aphagic, non-communicative, no response to verbal stimuli. PLEASE NOTE: hospital admission. Unable to complete section 21.  Admit for 4 days.
Full body rash, wide spread raised welts, hives, rashes, hot to touch. Temperatures between 100-102, tightness of throat, Benadrly and Zyrtec in double doses no to alleviate the throat tightness and full body rashes. The rashes and throat tightness began at day 5, and have worsened each day. Today is day 10, Starting Prednisone in hopes to get relief, as well as inhaler and Epi-pen prescribed as each night it seems to get worse. No history of any adverse reactions to any other vaccines or shots.
I had soreness on my shoulder that progressively extended to all of my upper arm and became more painful. I had difficulty raising my arm or moving it (it reminded me of the pain I felt when I had a case of bursitis on my other shoulder years prior). When lying down I could not sleep on that side and had difficulty sleeping on my right side as I could not find a comfortable position for my left arm that would not cause shooting pain. This lasted for 2-3 days. It subsided after 5 days. However, 10 days later, sometimes I get a softer pain on that arm when I move it. I did take extra strenght Tylenol, as recommended by the person that provided the shot. It did not help a lot, to be honest.
Localized adverse reaction. 7cm surrounding erythematous 3cm erythematous papule center. Warmth present.
Woke up the next morning with left eye ball pain; Eye felt sunburned; Vision is slightly off; Eye felt sunburned, vision is slightly off, light sensitive; Saw eye doctor at 3:15, symptoms were still present, mild inflammation was visible during exam; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6205) via an unspecified route of administration in the left arm on 02Mar2021 at 15:00 (at the age of 48-years-old) as a single dose for COVID-19 immunisation. Medical history included psoriatic arthritis, vitamin b12 deficiency, allergy to latex, banana and avocado. The patient did not receive any medication within two weeks of vaccination. The patient previously received prednisone (MANUFACTURER UNKNOWN) and cortisone (MANUFACTURER UNKNOWN); and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient woke up the next morning on 03Mar2021 at 07:15, with left eye ball pain. Eye felt sunburned, vision was slightly off, light sensitive. The events resulted in doctor or other healthcare professional office/clinic visit. The patient saw eye doctor at 15:15, symptoms were still present, mild inflammation was visible during examination. Therapeutic measures were taken as a result of the events and included treatment with paracetamol (TYLENOL) for pain. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events left eye ball pain; eye felt sunburned, vision was slightly off, light sensitive; mild inflammation was visible during examination were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Eyes itching, burning and mild crusting; Eyes itching, burning and mild crusting; Eyes itching, burning and mild crusting; This is a spontaneous report from a contactable other healthcare professional, the patient. A 39-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 16:45 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included herniated disc's, rheumatoid arthritis and known allergy to penicillin. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medication. The patient did not take any concomitant medication. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05Apr2021 at 20:45, the patient experienced eyes itching, burning and mild crusting. No tests just in person diagnosis. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events and included treatment with eye lubricant and azelastine and also reported that azelastine was given for the mild crusting. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events eyes itching, burning and mild crusting was not resolved at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
On 12-3-11 rec'd expired vaccine HIB lot #UH160AA exp 11-27-11 consider non-dose spoke w/ father will bring checked on 1-7-12 repeat dose.
OUT OF SPECIFICATION PRODUCT USE; THE VIAL WAS  PUNCTURED AT 9:30 AM AND THE PATIENT RECEIVED THE DOSE AT 6:08  PM; This spontaneous report received from a pharmacist concerned a 34 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included: Patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A,expiry: 21-SEP-2021) dose was not reported, administered on 06-AUG-2021 18:08 for prophylactic vaccination. No concomitant medications were reported. On 06-AUG-2021, the patient experienced out of specification product use. On 06-AUG-2021, the patient experienced the vial was punctured at 9:30 am and the patient received the dose at 6:08 pm. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the out of specification product use and the vial was punctured at 9:30 am and the patient received the dose at 6:08 pm was not reported. This report was non-serious.
after receiving the first dose of the Moderna Covid-19 her arm was sore; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (after receiving the first dose of the Moderna Covid-19 her arm was sore) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced VACCINATION SITE PAIN (after receiving the first dose of the Moderna Covid-19 her arm was sore). In 2021, VACCINATION SITE PAIN (after receiving the first dose of the Moderna Covid-19 her arm was sore) had resolved. Not provided.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Race of the patient was reported. Concomitant medications details were not reported.  The patient does not take any medicine. The patient was a Retired Registered Nurse who thought to received first dose of the vaccine was in the last week of Jan 2021 and had the sore arm lasted about 4 to 5 days.  No treatment medication were provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the moderna mailbox were missed to be booked-in.   This case was linked to MOD-2021-624848 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Significant Live Follow Up received on 27-Jul-21, included patient Demographics, Vaccination Start Date added and narrative updated.
The left arm started to itch, I scratched on top of the bandaid. The arm began to swell slightly. Itch started to spread deeper into the arm flesh. There was pain but not too bad. By Morning 5am Sunday the arm had a 3"x3" round oval red inflamed lump the size of a large egg. it is hot to the touch. It is spongy. It fells like a 2nd degree chemical burn. or sun burn. I tried witch-hazel. no difference. no change. I tried neosporin antibiotic clear cream. no change. I tried benedryl  oral 25mg. no change. I tried motrin 400mg and icing it. no change. I tried calamine lotion pink lotion dabbed on with cotton ball. slight change . it took the sting out slightly. and swelling down slightly. I will see the doctor on Tuesday 102423. I will most likely continue with calamine lotion.
Pt received a Pfizer vaccine for age group 5-11 years. Pt should have received a Pfizer vaccine for age 6months-4years
Patient's mother states rash on face Sunday morning. Then it spread all over entire body. Patient presents in clinic Tuesday with red, raised, fine rash covering entire body.
Fever, chills, fatigue, muscle aches, nausea, headache  all day on 1/19/20. Called the virtual hub to report symptoms and I am scheduled for a covid test today at 1 to be safe.
After receiving the vaccine, I sat down for 30 mins. I felt fine. I walked through the store for about 15mins. I felt dizzy when I got into the car. I walked around the house and within the hour of being home, the back of my right knee started to ache. It just kept aching so I finally went to my PCP. He said I need an MRI on my knee. The MRI showed I had inflammation behind my right knee, and I also had  a bakers cyst. Then I seen the orthopedic doctor and he said I should have a shot of steroids in my right knee which I have already gotten now.
Started with covid arm next day; Injection site warm; Pain going up back of neck; It is red about 4 inches long and 4 inches wide, It is extremely large., It is red, left arm extremely red (like an uneven sunburn); It is Itchy; Shoulder pain; By evening left arm was  verypainful; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION, VACCINATION SITE WARMTH, NECK PAIN, VACCINATION SITE ERYTHEMA, and VACCINATION SITE PAIN in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 032F21A, 011L20A, and 012MWA) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Drug allergy to Levoquin, Medrol PAK, and Sulfa. Concomitant products included VITAMIN D, VITAMIN B COMPLEX, and INFLUENZA VACCINE INACT SPLIT 3V (FLUZONE HIGH DOSE) for an unknown indication.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Oct-2021 at 11:15 AM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 ml. On 30-Oct-2021, the patient experienced VACCINATION SITE PAIN. On 31-Oct-2021, the patient experienced VACCINATION COMPLICATION, VACCINATION SITE WARMTH, NECK PAIN, and VACCINATION SITE ERYTHEMA. It is red, left arm extremely red. 31-Oct-2021, the patient experienced VACCINATION SITE PRURITUS and ARTHRALGIA. At the time of the report, VACCINATION COMPLICATION, VACCINATION SITE WARMTH, NECK PAIN, VACCINATION SITE PAIN, VACCINATION SITE PRURITUS, and ARTHRALGIA outcome was unknown, and VACCINATION SITE ERYTHEMA had not resolved.            No treatment information was provided. The patient was recommended to put cool compression. This case was linked to MOD-2021-008089, MOD-2021-373331 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes on 02-Nov-2021 allergy details, new concomitant medication, new event of itchy, By evening left arm was very painful, pain going up back of neck, and shoulder pain.
Swollen, painful lymph in armpit region in the same arm shot was received.; Swollen, painful lymph in armpit region in the same arm shot was received.; This is a spontaneous report from a contactable Consumer.   A 25-years-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in Arm Left on 09Mar2021 15:00 (Batch/Lot Number: EN6206) (at the age of 25) as single dose for covid-19 immunisation. Medical history included hypothyroidism. No known allergies. First dose was administered on 16Feb2021 15:00 right arm (lot# EL8982). Concomitant medications included levothyroxine taken for an unspecified indication, bupropion hydrochloride (WELLBUTRIN) taken for an unspecified indication, sertraline taken for an unspecified indication. The patient experienced swollen, painful lymph in armpit region in the same arm shot was received on 11Mar2021. No covid tested post vaccination. No covid prior vaccination. No treatment received. The outcome was recovering.  No follow-up attempts are possible. No further information is expected.
p/ pt recv vax approx 1yr later exp chickenpox. rpt MD noted 30-40 lesions & pt was afebrile
This case was reported by a consumer via call center representative and described the occurrence of stomach pain in a 64-year-old female patient who received SHINGRIX for prophylaxis. On 4th March 2019, the patient received the 1st dose of SHINGRIX. On 6th March 2019, 2 days after receiving SHINGRIX, the patient experienced stomach pain, fever, shivering, headache, fatigue, injection site pain, injection site swelling and injection site erythema. On an unknown date, the outcome of the stomach pain was not recovered/not resolved and the outcome of the fever, shivering, headache, fatigue, injection site pain, injection site swelling and injection site erythema were recovered/resolved. It was unknown if the reporter considered the stomach pain, fever, shivering, headache, fatigue, injection site pain, injection site swelling and injection site erythema to be related to SHINGRIX. Additional details were provided as follows: The case was reported by the patient for herself. The patient received a dose of SHINGRIX into the left arm and developed shivering, fever, headache, fatigue, stomach pain as well as soreness, redness, and swelling around the injection site. In March 2019, all the events had resolved except the stomach pain. The patient asked if there was any research which showed stomach pain lasted longer than the median duration. The patient did not know if it was intramuscular injection as she said her pharmacist gave it to her and she did not know the lot number or expiration date. The patient did not give the permission to contact her physician. Instead, she referred to her health care professional for additional information and follow up.